1 |
Kelley JR, Duggan JM . Gastric cancer epidemiology and risk fac- tors[ J] .Clin Epidemiol, 2003 ; 56: 1-9
|
2 |
Diaz rubio E .New chemotherapeutic advances in Pancreatic, Colorectal and Gastric cancer[ J] .Oncologist, 2004 ; 9: 282-94
|
3 |
Kang HC, Kim IJ, Park JH, Shin Y, Ku JL, Jung MS, et al . Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligo- nucleotide Microarrays[ J] . Clinical Cancer Res, 2004 ; 10: 272- 84
|
4 |
Lu HF, Sue CC, Yu CS, Chen SC, Chen GW, Chung JG.Diallyl disulfide ( DADS) induced apoptosis undergo caspase-3 activity in human bladder cancer T24 cells[ J] . Food Chem Toxicol, 2004; 42 : 1543-52
|
5 |
Elbashir SM, Lendeckel W, Tuschl T.RNA interference is medi- ated by 21 and 22nt RNAs[ J] . Genes Dev, 2001; 15: 188 -200
|
6 |
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tus- chl T.Duplexes of 21-nucleotide RNAs mediate RNA interfer- ence in mammalian cell culture[ J] . Nature, 2001; 411 : 494 -8
|
7 |
LZender, S Kubicka. siRNA based strategies for inhibition of ap- optotic pathways in vivo-analytical and therapeutic implications [ J] . Apoptosis, 2004; 9: 51 -4
|
8 |
Ren′e H, MEDEMA.Optimizing RNA interference for applica- tion in mammalian cells[ J] . Biochem J, 2004 ; 380: 593-603
|
9 |
Simon WJ, Patricia MS, Mark AL. siRNA for gene silencing:a route to drug target discovery[ J] . Currt Opin Pharmacoly , 2004; 4: 522-7
|
10 |
Yair D, Thomas T . siRNAs:Applications in functional genomics and potential as therapeutics[ J] .Nature Review Drug Disc, 2004 ; 3: 318 -29
|
11 |
Zhou J, Chen Y, Li C, Wang B, Wang B, Qiao Z .Relationship between bc l - X ( L) expression and sensitivity to chemotherapy in acute myeloid leukemic cells[ J] .Chin J Hematol, 1997; 18: 584 -7
|
12 |
Nakata B, Muguruma K, Hirakawa K, Chung YS, Yamashita Y, Inoue T, et al .Predictive value of Bc l - 2 and Bax protein ex- pression for chemotherapeutic effect in gastric cancer a pilot study[ J] .Oncology , 1998; 55: 543 -7
|
13 |
Satomi D, Takiguchi N, Koda K, Oda K, Suzuki H, Yasutomi J, et al .Apoptosis and apoptosis-associated gene products related to the response to neoadjuvant chemotherapy for gastric cancer [ J] . Int J Oncol, 2002 ; 20: 1167-71
|
14 |
Kondo S, Shinomura Y, Kanayama S, Higashimoto Y, Kiyohara T, Zushi S, et al .Modulation of apoptosis by endogenous Bcl- xL expression in MK4N-5 human gastric cancer cells[ J] .Onco- gene, 1998; 17 :2585-91
|
15 |
Simonian PL, Grillot DA, Nunez G. Bcl-2 and Bc l - XL can differ- entially block chemotherapy-induced cell death[ J] . Blood, 1997; 90: 1208-16
|
16 |
Yuan JP, Wang GH, Ling H, Su Q, Yang YH, Song Y, et al . Diallyl disulfide-induced G2 M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways [ J] .World J Gastroenterol, 2004 ; 10: 2731-34
|
17 |
Sundaram SG, Milner JA.Dially l disulfide induces apoptosis of human colon tumor cells[ J] .Carcinogenesis, 1996; 17 : 669-73
|
18 |
Nakagawa H, Tsuta K, Kiuchi K, Senzaki H, Tanaka K, Hioki K, et al .Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines[ J] .Carcinogenesis, 2001 ; 22: 891-7
|
19 |
Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, et al .Diallyl trisulfide-induced apoptosisin human prostate cancer cells involves c-Jun N-terminal kinase and extracellular- signal regulated kinase-mediated phosphorylation of Bcl-2[ J] . Oncogene, 2004; 23 : 5594 -606
|